HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christine Katlama Selected Research

Encephalitis (Encephalitis, Rasmussen)

9/2010HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis.
4/2006Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir.
3/2002Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christine Katlama Research Topics

Disease

32Infections
01/2022 - 01/2002
23HIV Infections (HIV Infection)
01/2018 - 05/2003
15Acquired Immunodeficiency Syndrome (AIDS)
01/2023 - 04/2003
12Viremia
01/2020 - 11/2008
10Hepatitis B
01/2023 - 01/2002
9Neoplasms (Cancer)
01/2022 - 01/2006
8Coinfection
02/2024 - 03/2003
7Fibrosis (Cirrhosis)
12/2020 - 03/2003
6Inflammation (Inflammations)
01/2021 - 01/2012
4Hypertension (High Blood Pressure)
10/2023 - 07/2011
4Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 01/2020
4Weight Gain
01/2023 - 10/2020
4Insulin Resistance
12/2020 - 02/2009
4Persistent Infection
02/2015 - 05/2002
4Liver Cirrhosis (Hepatic Cirrhosis)
10/2013 - 03/2003
4Human Influenza (Influenza)
07/2013 - 02/2008
4Exanthema (Rash)
01/2010 - 09/2003
4Disease Progression
01/2008 - 10/2002
3Lipodystrophy
01/2023 - 02/2016
3Hypersensitivity (Allergy)
06/2014 - 09/2003
3Chronic Hepatitis C
01/2014 - 07/2004
3Encephalitis (Encephalitis, Rasmussen)
09/2010 - 03/2002
3Opportunistic Infections (Opportunistic Infection)
01/2006 - 12/2002
2COVID-19
02/2024 - 03/2022
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023 - 01/2019
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2018 - 03/2008
2Necrosis
07/2017 - 01/2012
2Metabolic Bone Diseases (Osteopenia)
11/2015 - 09/2013
2Urolithiasis
01/2014 - 09/2007
2Virus Diseases (Viral Diseases)
04/2012 - 07/2004
2Hepatitis
11/2010 - 04/2010
2Injection Site Reaction
09/2010 - 12/2005
2Thrombocytopenia (Thrombopenia)
12/2009 - 07/2004
2Nausea
08/2006 - 12/2005
2Hepatitis C
05/2006 - 01/2005
1Hepatitis A (Hepatitis, Infectious)
01/2023
1Lymphoma (Lymphomas)
01/2020
1Kaposi Sarcoma (Kaposi's Sarcoma)
01/2020
1Myocardial Infarction
01/2020

Drug/Important Bio-Agent (IBA)

21RNA (Ribonucleic Acid)IBA
01/2019 - 05/2003
16Raltegravir PotassiumFDA Link
01/2023 - 07/2008
11Protease Inhibitors (Protease Inhibitor)IBA
10/2023 - 03/2004
10NucleosidesIBA
01/2022 - 05/2003
9Tenofovir (Viread)FDA Link
01/2023 - 02/2007
8Reverse Transcriptase InhibitorsIBA
01/2022 - 05/2003
8DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2012
8VaccinesIBA
02/2016 - 12/2002
8Ritonavir (Norvir)FDA Link
01/2014 - 05/2003
7dolutegravirIBA
10/2023 - 03/2013
6Lamivudine (Epivir)FDA Link
01/2023 - 01/2002
6Atazanavir Sulfate (Reyataz)FDA Link
01/2020 - 05/2006
6Biomarkers (Surrogate Marker)IBA
10/2014 - 03/2003
5abacavir (Ziagen)FDA Link
01/2023 - 09/2003
5etravirine (TMC-125)FDA Link
10/2020 - 11/2009
5Ribavirin (Virazole)FDA LinkGeneric
01/2017 - 01/2004
4Integrase InhibitorsIBA
10/2023 - 04/2009
4IntegrasesIBA
01/2023 - 01/2018
4AntibodiesIBA
03/2022 - 01/2006
4MaravirocFDA Link
01/2021 - 11/2010
4Emtricitabine (Emtriva)FDA Link
11/2017 - 01/2011
4InterferonsIBA
01/2017 - 05/2006
4Proteins (Proteins, Gene)FDA Link
02/2015 - 12/2002
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2012 - 03/2005
3Darunavir (Prezista)FDA Link
01/2020 - 04/2007
3Alanine Transaminase (SGPT)IBA
01/2019 - 02/2009
3Indinavir (Crixivan)FDA Link
01/2014 - 05/2003
3efavirenz (Sustiva)FDA Link
01/2011 - 09/2007
3Enfuvirtide (Fuzeon)FDA Link
09/2010 - 12/2005
3Interleukin-2 (IL2)IBA
03/2008 - 01/2002
2Antihypertensive Agents (Antihypertensives)IBA
10/2023 - 01/2023
2EnzymesIBA
01/2023 - 10/2009
2LipidsIBA
01/2023 - 10/2004
2tenofovir alafenamideIBA
01/2023 - 11/2015
2Immune Checkpoint InhibitorsIBA
01/2020 - 01/2019
2Transaminases (Aminotransferases)IBA
01/2019 - 02/2009
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2017 - 11/2010
2CreatinineIBA
11/2015 - 06/2007
2BilirubinIBA
01/2014 - 02/2011
2FoscarnetFDA LinkGeneric
06/2012 - 01/2006
2Stavudine (Zerit)FDA LinkGeneric
01/2012 - 04/2007
2Viral RNAIBA
01/2012 - 01/2004
2Nevirapine (Viramune)FDA Link
01/2011 - 09/2003
2Hepatitis B e AntigensIBA
01/2011 - 03/2006
2CytokinesIBA
05/2010 - 04/2010
2Anti-Retroviral Agents (Antiretroviral Agents)IBA
10/2009 - 01/2006
2insulin receptor-related receptor (IRR)IBA
01/2008 - 03/2005
2adefovir dipivoxil (Hepsera)FDA Link
01/2008 - 05/2002
2LopinavirFDA Link
08/2006 - 11/2005
2Interferon alpha-2 (Roferon-A)FDA Link
05/2006 - 07/2004
1molnupiravirIBA
02/2024
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2023
1Papillomavirus Vaccines (HPV Vaccines)IBA
01/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2023
1doravirineIBA
01/2023
1Anti-HIV Agents (AIDS Drugs)IBA
01/2020

Therapy/Procedure

38Therapeutics
01/2022 - 04/2003
14Highly Active Antiretroviral Therapy (HAART)
01/2018 - 03/2002
4Drug Therapy (Chemotherapy)
01/2020 - 01/2006
2Immunotherapy
01/2022 - 01/2019
2Duration of Therapy
04/2010 - 02/2009